Pharmaceutical Investing Catalyst Biosciences Announces Korean Ministry of Food and Drug Safety Approves Addition of Sixth Cohort to the Phase 1/2 Trial of CB 2679d/ISU304
Pharmaceutical Investing Conatus Pharmaceuticals Announces Top-line Results from Phase 2b POLT-HCV-SVR Clinical Trial
Fortune Minerals Reports Successful NICO Project Bismuth Test Work Results for the Planned Alberta Refinery